You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GRMD-02

Showing 1 - 25 of 416
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Amyloidosis; Systemic Trial in Woolloongabba, Box Hill (AT02)

Not yet recruiting
  • Amyloidosis; Systemic
  • Woolloongabba, Queensland, Australia
  • +1 more
Jul 11, 2023

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

Urothelial Carcinoma of the Renal Pelvis and Ureter, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial (ST-02)

Not yet recruiting
  • Urothelial Carcinoma of the Renal Pelvis and Ureter
  • Transitional Cell Cancer of the Renal Pelvis and Ureter
  • (no location specified)
Nov 7, 2023

SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19 mRNA Vaccine (ZSVG-02-O)
  • COVID-19 Vaccine (Vero Cell) ,Inactivated
  • Dengfeng, Henan, China
  • +1 more
Nov 6, 2023

Exercise Performance Trial in Tainan (Placebo, Probiotic 1,Lactococcus lactis subsp. lactis, LY-66, Probiotic 2,Lactobacillus

Completed
  • Exercise Performance
  • Placebo
  • +3 more
  • Tainan, Taiwan
    Glac Biotech Co., Ltd.
Oct 15, 2023

Anal Fistula Trial (RD2 Ver.02, debridement and suturing the internal opening of anal fistula)

Not yet recruiting
  • Anal Fistula
  • RD2 Ver.02
  • debridement and suturing the internal opening of anal fistula
  • (no location specified)
Nov 29, 2022

Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

Not yet recruiting
  • Advanced Melanoma
  • IMC-F106C
  • +2 more
  • La Jolla, California
  • +61 more
Oct 31, 2023

Duchenne Muscular Dystrophy Trial in Portland (NS-089/NCNP-02)

Not yet recruiting
  • Duchenne Muscular Dystrophy
  • Portland, Oregon
    Shriners Hospital for Children
Aug 16, 2023

Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Trial (TmPSMA-02 CAR T Cells)

Not yet recruiting
  • Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
  • TmPSMA-02 CAR T Cells
  • (no location specified)
Sep 13, 2023

Sleep and Mood Quality Trial in India (VL-NL-02, Placebo)

Not yet recruiting
  • Sleep and Mood Quality
  • VL-NL-02
  • Placebo
  • Dombivli, Maharashtra, India
  • +4 more
Sep 20, 2023

Hypoxemia Trial in Cleveland (Data acquisition using DT-400 pulse oximetry system)

Recruiting
  • Hypoxemia
  • Data acquisition using DT-400 pulse oximetry system
  • Cleveland, Ohio
    Consolidated Research, Inc.
Aug 30, 2023

NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Autologous, engineered T Cells targeting TP53 R175H
  • Duarte, California
    City of Hope
May 17, 2023

Atopic Dermatitis Eczema Trial in Montréal (BBI-02 Capsule, Placebo)

Recruiting
  • Atopic Dermatitis Eczema
  • FRTX-02 Capsule
  • Placebo
  • MontrĂ©al, Quebec, Canada
    Syneos Health Quebec
Sep 12, 2022

Pancreatic Ductal Adenocarcinoma Trial in New York (VSV-GP154, ATP150, ATP152)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • New York, New York
    NYU Langone Health
May 4, 2023

Porto-Venous Radiomics in Pancreatic Cancer

Recruiting
  • Pancreatic Cancer
  • Non-Interventional
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Jan 17, 2023

Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

Not yet recruiting
  • Leber Hereditary Optic Neuropathy (LHON)
  • NFS-02 Injection
  • (no location specified)
Apr 6, 2023

Autosomal Recessive Ichthyosis Trial in Rancho Santa Margarita (KB105, Placebo)

Not yet recruiting
  • Autosomal Recessive Ichthyosis
  • KB105
  • Placebo
  • Rancho Santa Margarita, California
    Mission Dermatology
Feb 20, 2023

Breast Cancer Trial in United States (Placebo, GLSI-100)

Recruiting
  • Breast Cancer
  • Placebo
  • GLSI-100
  • Birmingham, Alabama
  • +21 more
Jan 30, 2023

Advanced Solid Tumors Trial in Australia, China, United States (EMB-02)

Recruiting
  • Advanced Solid Tumors
  • EMB-02
  • Colorado Springs, Colorado
  • +5 more
Mar 28, 2022

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Venous Leg Ulcer, Diabetic Foot Ulcer Trial in Tamarac, Las Vegas, Chapel Hill (EscharEx (EX-02 formulation))

Completed
  • Venous Leg Ulcer
  • Diabetic Foot Ulcer
  • EscharEx (EX-02 formulation)
  • Tamarac, Florida
  • +2 more
Jul 24, 2022

Acute Esophageal Variceal Hemorrhage Trial in Hanzhou (Growth Inhibitor)

Recruiting
  • Acute Esophageal Variceal Hemorrhage
  • Growth Inhibitor
  • Hanzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 22, 2023

Systemic Sclerosis With and Without Interstitial Lung Disease Trial in Canada, United States (ACE-1334, Placebo)

Recruiting
  • Systemic Sclerosis With and Without Interstitial Lung Disease
  • MK-2225
  • Placebo
  • Orlando, Florida
  • +2 more
Jan 30, 2023

Prostate Cancer, mCRPC, mCSPC Trial in United States (PRL-02, Prednisone, dexamethasone)

Recruiting
  • Prostate Cancer
  • +2 more
  • Jeffersonville, Indiana
  • +7 more
Aug 17, 2022